Challenges and opportunities associated with platelets in pancreatic cancer
Z Chen, X Wei, S Dong, F Han, R He, W Zhou - Frontiers in Oncology, 2022 - frontiersin.org
Pancreatic cancer is one of the most common malignant tumors in the digestive system with
a poor prognosis. Accordingly, better understanding of the molecular mechanisms and …
a poor prognosis. Accordingly, better understanding of the molecular mechanisms and …
[HTML][HTML] Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer
BACKGROUND Platelet count or complete blood count (CBC)-based ratios including
lymphocyte-to-monocyte (LMR), neutrophil-to-lymphocyte (NLR), hemoglobin-to-platelet …
lymphocyte-to-monocyte (LMR), neutrophil-to-lymphocyte (NLR), hemoglobin-to-platelet …
Analysis of systemic inflammatory and coagulation biomarkers in advanced cervical cancer: Prognostic and predictive significance
N Li, Y Zhang, W Qu, C Zhang, Z Ding… - The International …, 2023 - journals.sagepub.com
Objective Peripheral systemic inflammatory, nutritional, and coagulation biomarkers have
prognostic and predictive value in various malignancies. We evaluated the prognostic and …
prognostic and predictive value in various malignancies. We evaluated the prognostic and …
Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?
M Dank, D Mühl, M Herold, L Hornyák… - Journal of Clinical …, 2022 - mdpi.com
Background: Programmed death-ligand 1 (PD-L1) and programmed cell death protein 1 (PD-
1) have been reported as possibly favorable prognostic factors in colorectal cancer (CRC) …
1) have been reported as possibly favorable prognostic factors in colorectal cancer (CRC) …
Histopathological chromogranin A-positivity is associated with right-sided colorectal cancers and worse prognosis
Z Herold, M Dank, M Herold, P Nagy, K Rosta… - Cancers, 2020 - mdpi.com
Simple Summary Several factors are known to affect colorectal cancer (CRC) patient
survival, including elevated platelet counts (thrombocytosis) and chromogranin A-positive …
survival, including elevated platelet counts (thrombocytosis) and chromogranin A-positive …
Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?
G Herczeg, A Somogyi, M Herold, A Fodor, K Rosta… - Open …, 2022 - degruyter.com
Background A large variety of factors can affect colorectal cancer (CRC) survival, including
type 2 diabetes mellitus (T2DM) and paraneoplastic thrombocytosis. Although several …
type 2 diabetes mellitus (T2DM) and paraneoplastic thrombocytosis. Although several …
[PDF][PDF] Investigation of paraneoplastic thrombocytosis in colorectal cancer patients with or without type 2 diabetes mellitus
G Herczeg - 2024 - repo.lib.semmelweis.hu
A colorectalis carcinoma (CRC) a harmadik leggyakoribb tumoros megbetegedés
világszerte. A GLOBOCAN 2020-as adatai alapján évente több, mint 1, 9 millió új esetet …
világszerte. A GLOBOCAN 2020-as adatai alapján évente több, mint 1, 9 millió új esetet …